Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$81,168,495
+$32,303,712 QoQ
Shares Held
322,558
+43.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#288
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Waverly Advisors, LLC holds $406,112,967 across 14 Drug Manufacturers - General names. ABBV ranks #2 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
97,676 | $117,155,534 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
322,558 | $81,168,495 | |
| 3 | JNJ |
Johnson & Johnson
|
314,877 | $79,969,311 | |
| 4 | MRK |
Merck & Co., Inc.
|
260,499 | $33,474,121 | |
| 5 | AZN |
Astrazeneca PLC
|
119,233 | $22,608,961 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
349,560 | $20,141,647 | |
| 7 | GSK |
GSK plc
|
290,593 | $15,232,885 | |
| 8 | AMGN |
Amgen Inc
|
41,925 | $15,181,881 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,168,495 | 322,558 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $48,864,783 | 224,676 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $50,010,977 | 218,876 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $36,803,283 | 158,950 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,678,224 | 159,887 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,317,373 | 149,472 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,318,218 | 114,340 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,542,028 | 98,957 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $17,303,279 | 100,882 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,582,483 | 96,554 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,932,384 | 31,828 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $4,402,933 | 29,538 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $3,552,559 | 26,368 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $3,726,229 | 23,381 | Shares | Other | 2023-05-16 | |
| 2022-12-31 | $5,095,239 | 31,528 | Shares | Other | 2023-02-15 | |
| 2022-09-30 | $3,848,874 | 28,678 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $653,074 | 4,264 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $630,931 | 3,892 | Shares | Other | 2022-05-17 | |
| 2021-12-31 | $540,516 | 3,992 | Shares | Other | 2022-02-15 | |
| 2021-09-30 | $373,338 | 3,461 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $389,847 | 3,461 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $295,765 | 2,733 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $233,265 | 2,177 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $211,967 | 2,420 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $230,330 | 2,346 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||